👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 98/100
Accepting new patients
Prof
Prof Suneil Jain
Oncology
English
4,253+
Patients seen
12
Years in practice
3
Publications
1
Languages spoken
About
Professor Suneil Jain is a caring and empathetic
Consultant Clinical Oncologist who is committed to providing patients with
clear information, answering all their questions, and ensuring they receive the
highest standard of care. He is an internationally recognised expert in the
management of prostate cancer and is passionate about improving outcomes
through clinical research and trials.
Professor Jain specialises in the treatment of prostate
cancer using advanced radiotherapy techniques, including stereotactic
radiotherapy. He is an expert in the insertion of gold fiducial markers and
peri-rectal spacers (Barrigel, SpaceOAR Vue) to help reduce the side effects of
radiotherapy. He also treats patients with systemic therapies, including novel
hormone treatments such as relugolix, abiraterone, and darolutamide. He has
extensive experience in active surveillance and uses advanced imaging techniques,
such as PSMA PET-CT, to aid in accurate staging when needed.
Originally from the North West of Northern Ireland,
Professor Jain graduated in Medicine from Queen’s University Belfast in 1999.
After completing specialist training in Oncology, he undertook an international
fellowship at the University of Toronto, focusing on prostate cancer. He has
been a Consultant Clinical Oncologist at the Northern Ireland Cancer Centre,
Belfast Trust, since 2012 and was appointed Professor of Clinical Oncology at
Queen’s University Belfast in 2020.
As an innovator in his field, Professor Jain has led efforts
to reduce treatment side effects and improve outcomes for men with prostate
cancer. He performed several first-in-Northern-Ireland procedures, including
transperineal prostate biopsies, transperineal fiducial marker insertions, and
the first use of SpaceOAR and Barrigel. He introduced HDR brachytherapy for
prostate cancer and stereotactic radiotherapy for both prostate cancer and
oligometastatic disease. He leads multiple clinical trials involving drug and
radiotherapy treatments and serves on national and international trial
management groups.
Professor Jain is a former Chair of the Irish Radiation Research Society and currently serves as Co-Director of the FASTMAN UK Prostate
Cancer Centre of Excellence. He is also Co-Director of the ProEx Prostate
Cancer Centre of Excellence in Belfast. He has been an invited member of the
American Society of Clinical Oncology Genitourinary Guidelines Development
Group, the UK National Cancer Research Institute’s prostate cancer clinical
studies group, and the Northern Ireland Cancer Network radiotherapy clinical
reference group.
He has published widely in leading journals, including the New
England Journal of Medicine, Lancet Oncology, and Journal of
Clinical Oncology. He is also deeply committed to educating and mentoring
the next generation of oncologists, particularly those with a passion for
academic oncology.
Consultant Clinical Oncologist who is committed to providing patients with
clear information, answering all their questions, and ensuring they receive the
highest standard of care. He is an internationally recognised expert in the
management of prostate cancer and is passionate about improving outcomes
through clinical research and trials.
Professor Jain specialises in the treatment of prostate
cancer using advanced radiotherapy techniques, including stereotactic
radiotherapy. He is an expert in the insertion of gold fiducial markers and
peri-rectal spacers (Barrigel, SpaceOAR Vue) to help reduce the side effects of
radiotherapy. He also treats patients with systemic therapies, including novel
hormone treatments such as relugolix, abiraterone, and darolutamide. He has
extensive experience in active surveillance and uses advanced imaging techniques,
such as PSMA PET-CT, to aid in accurate staging when needed.
Originally from the North West of Northern Ireland,
Professor Jain graduated in Medicine from Queen’s University Belfast in 1999.
After completing specialist training in Oncology, he undertook an international
fellowship at the University of Toronto, focusing on prostate cancer. He has
been a Consultant Clinical Oncologist at the Northern Ireland Cancer Centre,
Belfast Trust, since 2012 and was appointed Professor of Clinical Oncology at
Queen’s University Belfast in 2020.
As an innovator in his field, Professor Jain has led efforts
to reduce treatment side effects and improve outcomes for men with prostate
cancer. He performed several first-in-Northern-Ireland procedures, including
transperineal prostate biopsies, transperineal fiducial marker insertions, and
the first use of SpaceOAR and Barrigel. He introduced HDR brachytherapy for
prostate cancer and stereotactic radiotherapy for both prostate cancer and
oligometastatic disease. He leads multiple clinical trials involving drug and
radiotherapy treatments and serves on national and international trial
management groups.
Professor Jain is a former Chair of the Irish Radiation Research Society and currently serves as Co-Director of the FASTMAN UK Prostate
Cancer Centre of Excellence. He is also Co-Director of the ProEx Prostate
Cancer Centre of Excellence in Belfast. He has been an invited member of the
American Society of Clinical Oncology Genitourinary Guidelines Development
Group, the UK National Cancer Research Institute’s prostate cancer clinical
studies group, and the Northern Ireland Cancer Network radiotherapy clinical
reference group.
He has published widely in leading journals, including the New
England Journal of Medicine, Lancet Oncology, and Journal of
Clinical Oncology. He is also deeply committed to educating and mentoring
the next generation of oncologists, particularly those with a passion for
academic oncology.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Prof Suneil Jain
Education & training
-
2004–2010 MD · Medicine and Surgery
-
2010–2014 Residency · Oncology
-
2014–2015 Fellowship · Subspecialty training
Career & appointments
-
2014-09–2015-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
Allianz Professional · 5,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 2,869 |
| Annual physical exam | 99395 | 2,995 |
| Vaccination administration | 90471 | 187 |
| Minor procedure (skin) | 17110 | 2,220 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 450.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 180.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 10 · i10: 13
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.3868/euroclin.2025.0 · PMID: 33880639 · cited by 125
-
European registry analysis of Oncology outcomes
DOI: 10.7710/euroclin.2024.1 · PMID: 38927353 · cited by 159
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Society memberships
- WONCA Europe — Family Doctors — Member · since 2015
- national college of family doctors — Member · since 2015
- European Union of Medical Specialists (UEMS) — Member · since 2015
Patient reviews
- Bedside Manner
- 5.00
- Knowledge
- 5.00
- Wait Time
- 4.74
- Staff Friendliness
- 5.00
- Ease Of Appointment
- 4.89
- Value For Money
- 4.91
- Would Recommend Pct
- 99
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · suneil.jain@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
